Ekso Bionics Holdings, Inc. Common Stock Q4 FY2024 Earnings Call

· Earnings call transcript and AI-powered summary

Prepared remarks from CEO Scott Davis, CFO Jerome Wong, and COO Jason Jones. Focus on record Q4 revenue, gross margin expansion, cost discipline, and scaling the Ekso Indigo Personal go-to-market strategy via CMS reimbursement and new distribution partnerships.

Financial Highlights – Q4 2024 vs. Q4 2023

  • Revenue: $5.1 million (+5% YoY from $4.8 million) – record quarterly revenue.
  • Gross Profit & Margin: $2.7 million at 53% margin (vs. $2.4 million at 49% margin) – improvement driven by supply chain efficiencies and lower service costs.
  • Operating Expenses: $4.9 million (-15% YoY from $5.8 million) – reduced headcount, discretionary payroll, and consulting costs.
  • Net Loss: $3.4 million ($0.14 per basic/diluted share) vs. $3.2 million ($0.22 per share).
  • Cash Used in Operations: $1.4 million (vs. $1.6 million).

Financial Highlights – Full Year 2024 vs. Full Year 2023

  • Revenue: $17.9 million (vs. $18.3 million) – marginal decline attributed to 2023 procurement cycles with large IDNs and delivery of ~$2M VA pipeline inherited from the 2022 Parker Hannifin acquisition; 2024 focused on rebuilding that pipeline.

Continue Reading

Unlock the full AI-powered summary with key highlights, financial performance, and analyst Q&A.

Upgrade to Professional
Operator: Greetings. And welcome to the Ekso Bionics Holdings, Inc. Fourth Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone else requires operator assistance, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce Steven Kilmer. Thank you. Steven Kilmer: Thank you, operator, and good afternoon, everyone. Earlier today, Ekso Bionics Holdings, Inc. released financial results for the quarter and year ended December 31, 2024. A copy of the press release is available on our website. I would like to point out that management will make statements during this call that include forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that are not statements of historical facts shall be deemed to be forward-looking statements. All forward-looking statements, including statements regarding our business strategy, future financial or operational expectations, or our expectations of the regulatory landscape governing our products and operations, are based upon management's current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events t

Continue Reading

Unlock the full earnings call transcript with speaker labels and formatted dialogue.

Upgrade to Professional